STING1 and cancer: In summary, this study establishes a transformative platform that combines photonic metabolic reprogramming with cGAS–STING‐driven innate immune activation to overcome two key barriers in cancer immunotherapy: T‐cell exhaustion and insufficient systemic immune coverage.